This case study explores how one pharmaceutical brand responded to a significant formulary loss, implementing seamless provider prior authorization strategies through CoverMyMeds to mitigate impact and maintain market share in a highly competitive class.
This eBook, From Prescribing to Pick Up: Navigating the Access & Affordability Landscape, provides a focused view into CoverMyMeds’ access and affordability solutions and how they help biopharma brands overcome patient barriers. It highlights their integrated network, innovative technology, and human support services — including prior authorization solutions, hub services, and copay assistance — designed to streamline the patient journey, improve speed to therapy, and enhance health outcomes.
Point of Care and PatientPoint can improve the impact that your Pharma Reps are already having.
This whitepaper presents a structured analysis of prior authorization outcomes for RA treatments requiring medical benefit coverage. It examines real-world access barriers from the perspective of payer decision patterns, documentation requirements, site of care, and plan type. Unlike claims-based studies or survey-based research, this analysis draws from actual prior authorization cases, providing a direct window into the real-world challenges faced by prescribers and patients alike.
Case study on how a neuro biologic brand leveraged SamaCare’s insights and interventions platform to decrease patient access friction and improve patient starts.
Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.
There’s a reason your facility’s most sensitive operations are called “mission critical.” Learn how ABM’s highly technical management services can take the worry out of maintaining your most specialized systems.
Learn how our digital GMP solution ensures compliance with high regulatory standards, and offers faster, more accurate data access. By utilizing a mobile app for data collection and a management dashboard for task visibility and validation, it goes beyond traditional paper methods to meet growing industry needs.
Being proactive with and responsive to your environmental monitoring (EM) data helps prevent problems with cleanroom contamination. Learn more about EM and cleanroom best practices and to see how ABM can implement industry-leading cleanroom solutions for your facility.
As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.
This guide offers an in-depth analysis of the essential KPIs that market access teams should track to measure success particularly across speed of access, breadth of access, and price performance. It includes real-life use cases and practical steps on how to get started.
This guide equips early-stage, BD, and pre-launch market access teams with the foundations of analogue analysis, its benefits, approaches, and how to overcome common challenges. It also explains how AI can help streamline analogue analysis and deliver better results.
This article explores how optimizing next-generation sequencing (NGS) in oncology trials can enhance patient identification, boosts efficiency, and enables diverse recruitment.
AI-powered knowledge assistants are transforming pharmaceutical sales by providing field reps with instant access to accurate and compliant information, addressing challenges related to information overload and inconsistent messaging.
Market Data Analytics Buyer's Guide - Are you considering a medical claims data solution for healthcare business planning and strategy? Here’s how to make sense of the options.
Organizations that focus on improving patient outcomes and reducing healthcare costs rely on real-world data to guide and support their mission. Being able to extract meaningful insights from this data is vital.
When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
This application note summarizes key SIFT-MS results presented in a peer reviewed article entitled “Unreported VOC Emissions from Road Transport Including from Electric Vehicles.” Learn how the Wolfson Atmospheric Chemistry Laboratory at the University of York used SIFT-MS for VOC analysis in its platform to experimentally verify that motor vehicle screen wash is a significant unreported source of VOC emissions (especially for ethanol and methanol).
